Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Spring Venture Ltd Oriental currently holds 529,762 shares of Terns Pharmaceuticals, Inc. (TERN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Spring Venture Ltd Oriental has been a net seller of TERN stock. They have purchased $0 and sold $8.3M worth of shares.
Spring Venture Ltd Oriental's most recent insider trade was on Nov 23, 2022, when they sold 166,666 shares at $5.50 per share.
Spring Venture Ltd Oriental serves as Executive at Terns Pharmaceuticals, Inc. (TERN). They have executed 3 insider transactions totaling $8.3M over their tenure at the company.
Spring Venture Ltd Oriental holds the position of Executive at Terns Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Spring Venture Ltd Oriental has shown a selling trading pattern, with $0 in total purchases and $8.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Spring Venture Ltd Oriental was on Nov 23, 2022, when they sold $5.5M worth of TERN shares. This transaction involved 1,000,000 shares at $5.50 per share.
Spring Venture Ltd Oriental currently owns 529,762 shares of Terns Pharmaceuticals, Inc. (TERN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Spring Venture Ltd Oriental's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Spring Venture Ltd Oriental has 3 Form 4 filings on record as an insider at Terns Pharmaceuticals, Inc..
Set alerts for Spring Venture Ltd Oriental and 40,000+ other insiders.